NEW YORK (GenomeWeb) – The bioinformatics company formerly known as Omicia announced today that it will now be known as Fabric Genomics, and that it is launching a new end-to-end clinical genomics platform called Fabric Enterprise.

The Oakland, California-based firm also announced that it has signed a technology partnership agreement with bioinformatics firm Sentieon to enhance the platform's secondary analysis capabilities. The firms will co-develop new variant calling software for hereditary diseases and oncology with the aim of improving accuracy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.